Back to article: STING-driven activation of T cells: relevance for the adoptive cell therapy of cancer
53. Larkin B, Ilyukha V, Sorokin M, Buzdin A, Vannier E, Poltorak A (2017). Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death. J Immunol 199(2): 397-402. 10.4049/jimmunol.1601999
54. Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, Radtke F, Ablasser A (2017). Signalling strength determines proapoptotic functions of STING. Nat Commun 8(1): 427. 10.1038/s41467-017-00573-w
55. Benoit-Lizon I, Jacquin E, Rivera Vargas T, Richard C, Roussey A, Dal Zuffo L, Martin T, Melis A, Vinokurova D, Shahoei SH, Baeza Garcia A, Pignol C, Giorgiutti S, Carapito R, Boidot R, Végran F, Flavell RA, Ryffel B, Nelson ER, Soulas-Sprauel P, Lawrence T, Apetoh L (2022). CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T(H)1 and T(H)9 cells. J Immunother Cancer 10(1): e003459. 10.1136/jitc-2021-003459
56. Li W, Lu L, Lu J, Wang X, Yang C, Jin J, Wu L, Hong X, Li F, Cao D, Yang Y, Wu M, Su B, Cheng J, Yang X, Di W, Deng L (2020). cGAS-STING-mediated DNA sensing maintains CD8(+) T cell stemness and promotes antitumor T cell therapy. Sci Transl Med 12(549): eaay9013. 10.1126/scitranslmed.aay9013